# Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain

> **NCT01666197** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 100 (actual)

## Conditions studied

- Ankle Sprain

## Interventions

- **DRUG:** diclofenac potassium 25 mg tablet
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01666197
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666197, "Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01666197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*